Kevin Kuykendall, CEO of Vivione Biosciences, Discusses Startup Companies (Exec Q&A)

Kevin Kuykendall is the new chief executive at Vivione Biosciences, a Little Rock startup formerly known as Litmus Rapid-B.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access articles older than 15 days.
Articles newer than 15 days are not included in this offer.

Purchase Now

Already have archive access? Login to view this article.